Avalo Therapeutics Reports 2025 Financial Results and Recent Business Updates

AI Briefing

• – Avalo Therapeutics reports strong business updates and year-end financial results for 2025
• – The company is fully dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases
• – Avalo is a clinical stage biotechnology company on Nasdaq